In a recent article The New York Times reports Johnson & Johnson has “tentatively agreed to a settlement” that could see the company making up to $4 billion payments “to resolve thousands of lawsuits filed by patients injured by a flawed all-metal replacement hip,” according to two lawyers briefed on the plan.
The paper says that under the settlement, patients with the implanted device – the Articular Surface Replacement – can have it removed “and replaced with another artificial hip.” Also, each patient would get a payout of about $350,000 “on average.” The ASR hip implant was sold by the company’s DePuy Orthopaedics unit until mid-2010, “when the company recalled it amid sharply rising early failure rates.”
Click here to read the full article.